| Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance S Silva, M Negri, M Henriques, R Oliveira, DW Williams, J Azeredo FEMS microbiology reviews 36 (2), 288-305, 2012 | 1196 | 2012 |
| Critical review on biofilm methods J Azeredo, NF Azevedo, R Briandet, N Cerca, T Coenye, AR Costa, ... Critical reviews in microbiology 43 (3), 313-351, 2017 | 1001 | 2017 |
| Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors B Gonçalves, C Ferreira, CT Alves, M Henriques, J Azeredo, S Silva Critical reviews in microbiology 42 (6), 905-927, 2016 | 699 | 2016 |
| Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition S Silva, M Henriques, A Martins, R Oliveira, D Williams, J Azeredo Sabouraudia 47 (7), 681-689, 2009 | 468 | 2009 |
| Genetically engineered phages: a review of advances over the last decade DP Pires, S Cleto, S Sillankorva, J Azeredo, TK Lu Microbiology and Molecular Biology Reviews 80 (3), 523-543, 2016 | 447 | 2016 |
| Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis N Cerca, GB Pier, M Vilanova, R Oliveira, J Azeredo Research in microbiology 156 (4), 506-514, 2005 | 422 | 2005 |
| Bacteriophage-encoded depolymerases: their diversity and biotechnological applications DP Pires, H Oliveira, LDR Melo, S Sillankorva, J Azeredo Applied microbiology and biotechnology 100, 2141-2151, 2016 | 409 | 2016 |
| The use of phages for the removal of infectious biofilms J Azeredo, IW Sutherland Current pharmaceutical biotechnology 9 (4), 261-266, 2008 | 386 | 2008 |
| Bacteriophages and their role in food safety SM Sillankorva, H Oliveira, J Azeredo International journal of microbiology 2012, 2012 | 383 | 2012 |
| Adherence and biofilm formation of non-Candida albicans Candida species S Silva, M Negri, M Henriques, R Oliveira, DW Williams, J Azeredo Trends in microbiology 19 (5), 241-247, 2011 | 371 | 2011 |
| Engineered endolysin-based “Artilysins” to combat multidrug-resistant gram-negative pathogens Y Briers, M Walmagh, V Van Puyenbroeck, A Cornelissen, W Cenens, ... MBio 5 (4), 10.1128/mbio. 01379-14, 2014 | 339 | 2014 |
| Revisiting phage therapy: new applications for old resources FL Nobrega, AR Costa, LD Kluskens, J Azeredo Trends in microbiology 23 (4), 185-191, 2015 | 335 | 2015 |
| Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT … N Cerca, S Martins, F Cerca, KK Jefferson, GB Pier, R Oliveira, J Azeredo Journal of Antimicrobial Chemotherapy 56 (2), 331-336, 2005 | 324 | 2005 |
| The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? JP Pirnay, D De Vos, G Verbeken, M Merabishvili, N Chanishvili, ... Pharmaceutical research 28, 934-937, 2011 | 323 | 2011 |
| Molecular aspects and comparative genomics of bacteriophage endolysins H Oliveira, LDR Melo, SB Santos, FL Nóbrega, EC Ferreira, N Cerca, ... Journal of virology 87 (8), 4558-4570, 2013 | 288 | 2013 |
| The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens CM Carvalho, BW Gannon, DE Halfhide, SB Santos, CM Hayes, JM Roe, ... BMC microbiology 10, 1-11, 2010 | 280 | 2010 |
| Comparative Antibody-Mediated Phagocytosis of Staphylococcus epidermidis Cells Grown in a Biofilm or in the Planktonic State N Cerca, KK Jefferson, R Oliveira, GB Pier, J Azeredo Infection and immunity 74 (8), 4849-4855, 2006 | 280 | 2006 |
| Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections DP Pires, LDR Melo, DV Boas, S Sillankorva, J Azeredo Current opinion in microbiology 39, 48-56, 2017 | 251 | 2017 |
| Guidelines to cell engineering for monoclonal antibody production AR Costa, ME Rodrigues, M Henriques, J Azeredo, R Oliveira European Journal of Pharmaceutics and Biopharmaceutics 74 (2), 127-138, 2010 | 247 | 2010 |
| Phage therapy: going temperate? R Monteiro, DP Pires, AR Costa, J Azeredo Trends in microbiology 27 (4), 368-378, 2019 | 229 | 2019 |
Sanna SillankorvaINL - International Iberian Nanotechnology LaboratoryVerified email at inl.int
